Pancreatic Cancer Research

ResearcherDublin City UniversityNo recent work listed

Orla Coleman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4579-7522; OpenAlex author ID A5018463575. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: 1 paper

Papers 3

  1. Proteomic Analysis of Cell Lines and Primary Tumors in Pancreatic Cancer Identifies Proteins Expressed Only In Vitro and Only In Vivo. Co-author DOI 10.1097/mpa.0000000000001633↗
  2. A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts. Co-author DOI 10.3390/proteomes6040045↗
  3. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact. Co-author DOI 10.1586/14789450.2016.1167601↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Paula Meleady · 3 shared papers, 2016–2020 · strength 0.24
  2. Martin M. Clynes · 3 shared papers, 2016–2020 · strength 0.24
  3. Kevin C. Conlon · 2 shared papers, 2018–2020 · strength 0.17
  4. Sandra Roche · 2 shared papers, 2018–2020 · strength 0.17
  5. Fiona O’Neill · 2 shared papers, 2018–2020 · strength 0.17
  6. Robert M. Straubinger · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.